How does the dietary supplement Stasis affect attention-deficit/hyperactivity disorder (ADHD) and anxiety?

No Evidence Exists for the Supplement "Stasis" in ADHD or Anxiety Treatment

There is no scientific evidence, clinical guideline, or FDA approval for a supplement called "Stasis" in the treatment of ADHD or anxiety disorders. The provided medical literature contains no references to this product, and it does not appear in any established treatment guidelines for these conditions.

What the Evidence Actually Shows

Established ADHD Treatment Standards

The most recent guidelines consistently recommend:

• First-line pharmacotherapy: FDA-approved stimulants (methylphenidate, amphetamines) for moderate-to-severe ADHD show 65-75% improvement rates versus 5-30% for placebo 1
• Non-stimulant options: Atomoxetine, extended-release guanfacine, and extended-release clonidine as second-line agents 2
• Behavioral interventions: Cognitive behavioral therapy (CBT) has the strongest evidence among non-pharmacologic treatments 3

ADHD with Comorbid Anxiety

When ADHD and anxiety co-occur (a common scenario):

• Stimulants remain effective: Recent large trials show that ADHD patients with comorbid anxiety actually demonstrate enhanced treatment response to stimulants, contradicting older concerns 1
• Treatment sequencing: Start with stimulant trial for ADHD symptoms; if anxiety persists after ADHD improvement, add SSRI or pursue psychosocial intervention 1
• Combined approach: For elementary school-age children (6-11 years), both FDA-approved medications AND behavioral therapy are recommended, preferably together 2

Supplement Evidence in ADHD (What Actually Has Data)

While "Stasis" has no evidence, other supplements have been studied:

Supplements with Modest Evidence:

• Omega-3 fatty acids: Meta-analysis shows small but reliable improvements (effect size 0.26) in composite ADHD symptoms, particularly hyperactivity 4. Blood levels of omega-3 are lower in ADHD patients 4
• Micronutrient formulas: Some case studies show potential benefit for mood and ADHD symptoms 5, but evidence remains preliminary
• Astaxanthin: Recent animal studies suggest dopaminergic modulation 6, but human trials are lacking

Critical Limitations:

• Effect sizes are modest compared to FDA-approved medications
• Studies show mixed results with heterogeneous methodologies 7
• No supplement should replace established pharmacotherapy for moderate-to-severe ADHD 8

Clinical Pitfalls to Avoid

1. Unproven supplements: Products without peer-reviewed evidence or FDA approval carry unknown risks and may delay effective treatment
2. Symptom overlap: ADHD, anxiety, and depression share overlapping symptoms; accurate diagnosis requires collateral information from multiple settings 2
3. Untreated ADHD consequences: Delaying evidence-based treatment leads to impaired social, educational, and occupational outcomes extending into adulthood 9

What You Should Do Instead

For ADHD with anxiety:

• Initiate FDA-approved stimulant medication (methylphenidate 5-20 mg tid or dextroamphetamine 5 mg tid to 20 mg bid) 1
• Monitor response over 2-4 weeks
• If ADHD improves but anxiety persists, add evidence-based psychotherapy (CBT) or consider SSRI 1
• Ensure treatment addresses functional impairment in at least two settings (home, school, work) 2

If considering supplements:

• Only use as adjunctive therapy alongside established treatments
• Omega-3 supplementation (EPA/DHA) has the most evidence but shows only modest effects 4
• Monitor for lack of response and escalate to proven therapies promptly

Bottom line: Without any published evidence for "Stasis," recommending this product would be practicing outside evidence-based medicine. Stick with FDA-approved medications and guideline-recommended behavioral interventions that have demonstrated efficacy in thousands of patients across multiple randomized controlled trials.